EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions

Hsin-Ting Chen, Yulei Zhang, Jie Huang, Manali Sawant, Matthew D Smith, Nandhini Rajagopal, Alec A Desai, Emily Makowski, Giuseppe Licari, Yunxuan Xie, Michael S Marlow, Sandeep Kumar und 1 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Hsin-Ting Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI …. Hauptthemen laut MEDLINE: Complementarity Determining Regions, Immunoglobulin Heavy Chains. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complementarity Determining RegionsImmunoglobulin Heavy ChainsHumansAntibody SpecificityAntibodiesAmino Acid Sequence

Stichwörter der Autor:innen

CP: Immunologyantibody engineeringdeep sequencingdevelopabilitymachine learningnon-specific bindingnonspecificityoff-target bindingpharmacokineticpolyspecificityrepertoire

Substanzen

Complementarity Determining RegionsImmunoglobulin Heavy ChainsAntibodies

Autor:innen und Institutionen

  • Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michi…
  • Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.
  • Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA; Department of Biomedical Engineering, Univer…

Förderung

  • NIA NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Science Foundation
  • Boehringer Ingelheim
  • National Institutes of Health

Zitieren

APA

Chen, H. T., Zhang, Y., Huang, J., Sawant, M., Smith, M. D., Rajagopal, N., Desai, A. A., Makowski, E., Licari, G., Xie, Y., Marlow, M. S., Kumar, S., & Tessier, P. M. (2024). Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114801

Vancouver

Chen HT, Zhang Y, Huang J, Sawant M, Smith MD, Rajagopal N, et al. Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114801

BibTeX
@article{Chen2024,
  author = {Chen, Hsin-Ting and Zhang, Yulei and Huang, Jie and Sawant, Manali and Smith, Matthew D and Rajagopal, Nandhini and Desai, Alec A and Makowski, Emily and Licari, Giuseppe and Xie, Yunxuan and Marlow, Michael S and Kumar, Sandeep and Tessier, Peter M},
  title = {Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114801}
}
Kostenlos starten →